Sung H. Ferlay J. Siegel R.L. et al.

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.

CA Cancer J Clin. 71: 209-249Willett C.G. Czito B.G. Tyler D.S.

Intraoperative radiation therapy.

J Clin Oncol. 25: 971-977Lee J. Lim D.H. Kim S. et al.

Phase III trial comparing capecitabine plus cisplatin versus capecitabine plus cisplatin with concurrent capecitabine radiotherapy in completely resected gastric cancer with D2 lymph node dissection: the ARTIST trial.

J Clin Oncol. 30: 268-273Yu W.W. Guo Y.M. Zhang Q. et al.

Benefits from adjuvant intraoperative radiotherapy treatment for gastric cancer: A meta-analysis.

Mol Clin Oncol. 3: 185-189Gao P. Tsai C. Yang Y. et al.

Intraoperative radiotherapy in gastric and esophageal cancer: meta-analysis of long-term outcomes and complications.

Minerva Med. 108: 74-83Siegel R.L. Miller K.D. Fuchs H.E. et al.

Cancer statistics, 2022.

CA Cancer J Clin. 72: 7-33Patel S.H. Katz M.H.G. Ahmad S.A.

The Landmark Series: Preoperative Therapy for Pancreatic Cancer.

Ann Surg Oncol. 28: 4104-4129Suker M. Beumer B.R. Sadot E. et al.

FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis.

Lancet Oncol. 17: 801-810Janssen Q.P. O'Reilly E.M. van Eijck C.H.J. et al.

Neoadjuvant Treatment in Patients With Resectable and Borderline Resectable Pancreatic Cancer.

Front Oncol. 10: 41Murphy J.E. Wo J.Y. Ryan D.P. et al.

Total Neoadjuvant Therapy With FOLFIRINOX Followed by Individualized Chemoradiotherapy for Borderline Resectable Pancreatic Adenocarcinoma: A Phase 2 Clinical Trial.

JAMA Oncol. 4: 963-969Versteijne E. Suker M. Groothuis K. et al.

Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial.

J Clin Oncol. 38: 1763-1773Versteijne E. van Dam J.L. Suker M. et al.

Neoadjuvant Chemoradiotherapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Long-Term Results of the Dutch Randomized PREOPANC Trial.

J Clin Oncol. 40: 1220-1230Hammel P. Huguet F. van Laethem J.L. et al.

Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib: The LAP07 Randomized Clinical Trial.

JAMA. 315: 1844-1853Konstantinidis I.T. Warshaw A.L. Allen J.N. et al.

Pancreatic ductal adenocarcinoma: is there a survival difference for R1 resections versus locally advanced unresectable tumors? What is a "true" R0 resection?.

Ann Surg. 257: 731-736Iacobuzio-Donahue C.A. Fu B. Yachida S. et al.

DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer.

J Clin Oncol. 27: 1806-1813Krishnan S. Chadha A.S. Suh Y. et al.

Focal Radiation Therapy Dose Escalation Improves Overall Survival in Locally Advanced Pancreatic Cancer Patients Receiving Induction Chemotherapy and Consolidative Chemoradiation.

Int J Radiat Oncol Biol Phys. 94: 755-765Reyngold M. O'Reilly E.M. Varghese A.M. et al.

Association of Ablative Radiation Therapy With Survival Among Patients With Inoperable Pancreatic Cancer.

JAMA Oncol. 7: 735-738Calvo F.A. Asencio J.M. Roeder F. et al.

ESTRO IORT Task Force/ACROP recommendations for intraoperative radiation therapy in borderline-resected pancreatic cancer.

Clin Transl Radiat Oncol. 23: 91-99Calvo F.A. Krengli M. Asencio J.M. et al.

ESTRO IORT Task Force/ACROP recommendations for intraoperative radiation therapy in unresected pancreatic cancer.

Radiother Oncol. 148: 57-64Willett C.G. Lewandrowski K. Warshaw A.L. et al.

Resection margins in carcinoma of the head of the pancreas. Implications for radiation therapy.

Ann Surg. 217: 144-148Sindelar W.F. Kinsella T.J.

Studies of intraoperative radiotherapy in carcinoma of the pancreas.

Ann Oncol. 10: 226-230Valentini V. Calvo F. Reni M. et al.

Intra-operative radiotherapy (IORT) in pancreatic cancer: joint analysis of the ISIORT-Europe experience.

Radiother Oncol. 91: 54-59Ogawa K. Karasawa K. Ito Y. et al.

Intraoperative radiotherapy for resected pancreatic cancer: a multi-institutional retrospective analysis of 210 patients.

Int J Radiat Oncol Biol Phys. 77: 734-742Calvo F.A. Sole C.V. Atahualpa F. et al.

Chemoradiation for resected pancreatic adenocarcinoma with or without intraoperative radiation therapy boost: Long-term outcomes.

Pancreatology. 13: 576-582Harrison J.M. Wo J.Y. Ferrone C.R. et al.

Intraoperative Radiation Therapy (IORT) for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma (BR/LA PDAC) in the Era of Modern Neoadjuvant Treatment: Short-Term and Long-Term Outcomes.

Ann Surg Oncol. 27: 1400-1406Sekigami Y. Michelakos T. Fernandez-Del Castillo C. et al.

Intraoperative Radiation Mitigates the Effect of Microscopically Positive Tumor Margins on Survival Among Pancreatic Adenocarcinoma Patients Treated with Neoadjuvant FOLFIRINOX and Chemoradiation.

Ann Surg Oncol. 28: 4592-4601Jin L. Shi N. Ruan S. et al.

The role of intraoperative radiation therapy in resectable pancreatic cancer: a systematic review and meta-analysis.

Radiat Oncol. 15: 76Showalter T.N. Rao A.S. Rani Anne P. et al.

Does intraoperative radiation therapy improve local tumor control in patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma? A propensity score analysis.

Ann Surg Oncol. 16: 2116-2122Tepper J.E. Noyes D. Krall J.M. et al.

Intraoperative radiation therapy of pancreatic carcinoma: a report of RTOG-8505. Radiation Therapy Oncology Group.

Int J Radiat Oncol Biol Phys. 21: 1145-1149Mohiuddin M. Regine W.F. Stevens J. et al.

Combined intraoperative radiation and perioperative chemotherapy for unresectable cancers of the pancreas.

J Clin Oncol. 13: 2764-2768Ogawa K. Karasawa K. Ito Y. et al.

Intraoperative radiotherapy for unresectable pancreatic cancer: a multi-institutional retrospective analysis of 144 patients.

Int J Radiat Oncol Biol Phys. 80: 111-118Chen Y. Che X. Zhang J. et al.

Long-term results of intraoperative electron beam radiation therapy for nonmetastatic locally advanced pancreatic cancer: Retrospective cohort study, 7-year experience with 247 patients at the National Cancer Center in China.

Medicine (Baltim). 95: e4861Cai S. Hong T.S. Goldberg S.I. et al.

Updated long-term outcomes and prognostic factors for patients with unresectable locally advanced pancreatic cancer treated with intraoperative radiotherapy at the Massachusetts General Hospital, 1978 to 2010.

Cancer. 119: 4196-4204Jarnagin W.R. Fong Y. DeMatteo R.P. et al.

Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma.

Ann Surg. 234 (): 507-517

Desmoplastic stroma and cholangiocarcinoma: clinical implications and therapeutic targeting.

Hepatology. 59: 2397-2402Todoroki T. Kawamoto T. Otsuka M. et al.

Benefits of combining radiotherapy with aggressive resection for stage IV gallbladder cancer.

Hepato-Gastroenterology. 46: 1585-1591Lindell G. Holmin T. Ewers S.B. et al.

Extended operation with or without intraoperative (IORT) and external (EBRT) radiotherapy for gallbladder carcinoma.

Hepato-Gastroenterology. 50: 310-314Monson J.R. Donohue J.H. Gunderson L.L. et al.

Intraoperative radiotherapy for unresectable cholangiocarcinoma--the Mayo Clinic experience.

Surg Oncol. 1: 283-290Kaiser G.M. Fruhauf N.R. Lang H. et al.

Impact of intraoperative radiotherapy (IORT) on survival of patients with unresectable hilar cholangiocarcinoma.

Hepato-Gastroenterology. 55: 1951-1954Fisher B. Wolmark N. Rockette H. et al.

Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01.

J Natl Cancer Inst. 80: 21-29Conroy T. Bosset J.F. Etienne P.L. et al.

Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial.

Lancet Oncol. 22: 702-715Masaki T. Matsuoka H. Kishiki T. et al.

Site-specific risk factors for local recurrence after rectal cancer surgery.

Surg Oncol. 37: 101540Maas M. Nelemans P.J. Valentini V. et al.

Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data.

Lancet Oncol. 11: 835-844Braendengen M. Tveit K.M. Berglund A. et al.

Randomized phase III study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer.

J Clin Oncol. 26: 3687-3694Dubois J.B. Bussieres E. Richaud P. et al.

Intra-operative radiotherapy of rectal cancer: results of the French multi-institutional randomized study.

Radiother Oncol. 98: 298-303Masaki T. Matsuoka H. Kishiki T. et al.

Intraoperative radiotherapy for resectable advanced lower rectal cancer-final results of a randomized controlled trial (UMIN000021353).

Langenbeck's Arch Surg. 405: 247-254Kusters M. Valentini V. Calvo F.A. et al.

Results of European pooled analysis of IORT-containing multimodality treatment for locally advanced rectal cancer: adjuvant chemotherapy prevents local recurrence rather than distant metastases.

Ann Oncol. 21: 1279-1284Holman F.A. Haddock M.G. Gunderson L.L. et al.

Results of intraoperative electron beam radiotherapy containing multimodality treatment for locally unresectable T4 rectal cancer: a pooled analysis of the Mayo Clinic Rochester and Catharina Hospital Eindhoven.

J Gastrointest Oncol. 7: 903-916Haddock M.G. Miller R.C. Nelson H. et al.

Combined modality therapy including intraoperative electron irradiation for locally recurrent colorectal cancer.

Int J Radiat Oncol Biol Phys. 79: 143-150Suzuki K. Gunderson L.L. Devine R.M. et al.

Intraoperative irradiation after palliative surgery for locally recurrent rectal cancer.

Cancer. 75: 939-952Valentini V. Morganti A.G. De Franco A. et al.

Chemoradiation with or without intraoperative radiation therapy in patients with locally recurrent rectal carcinoma: prognostic factors and long term outcome.

Cancer. 86: 2612-2624Holman F.A. Bosman S.J. Haddock M.G. et al.

Results of a pooled analysis of IOERT containing multimodality treatment for locally recurrent rectal cancer: Results of 565 patients of two major treatment centres.

Eur J Surg Oncol. 43: 107-117Mirnezami R. Chang G.J. Das P. et al.

Intraoperative radiotherapy in colorectal cancer: systematic review and meta-analysis of techniques, long-term outcomes, and complications.

Surg Oncol. 22: 22-35Fahy M.R. Kelly M.E. Power Foley M. et al.

The role of intraoperative radiotherapy in advanced rectal cancer: a meta-analysis.

Colorectal Dis. 23: 1998-2006Liu B. Ge L. Wang J. et al.

Efficacy and safety of intraoperative radiotherapy in rectal cancer: A systematic review and meta-analysis.

World J Gastrointest Oncol. 13: 69-86Roeder F. Goetz J.M. Habl G. et al.

Intraoperative Electron Radiation Therapy (IOERT) in the management of locally recurrent rectal cancer.

BMC Cancer. 12: 592Sole C.V. Calvo F.A. Serrano J. et al.

Post-chemoradiation intraoperative electron-beam radiation therapy boost in resected locally advanced rectal cancer: long-term results focused on topographic pattern of locoregional relapse.

Radiother Oncol. 112: 52-58Hyngstrom J.R. Tzeng C.W. Beddar S. et al.

Intraoperative radiation therapy for locally advanced primary and recurrent colorectal cancer: ten-year institutional experience.

J Surg Oncol. 109: 652-658Zhang Q. Tey J. Yang Z. et al.

Intraoperative radiotherapy in the combination of adjuvant chemotherapy for the treatment of pT3N0M0 rectal cancer after radical surgery.

Am J Clin Oncol. 37: 8-12Zhang Q. Tey J. Yang Z. et al.

Adjuvant chemoradiation plus intraoperative radiotherapy versus adjuvant chemoradiation alone in patients with locally advanced rectal cancer.

Am J Clin Oncol. 38: 11-16